{
    "title": "Drug slashes risk of death for women with high-risk breast cancer by 32%",
    "url": "https://www.dailymail.co.uk/wires/pa/article-10620409/Drug-slashes-risk-death-women-high-risk-breast-cancer-32.html",
    "date": "2022-03-16",
    "keywords": [
        "cancer",
        "breast",
        "treatment",
        "drug",
        "olaparib",
        "research",
        "brca",
        "risk",
        "chance",
        "earlystage",
        "death",
        "type",
        "mutation",
        "jolie",
        "lynparza",
        "society",
        "oncology",
        "congress",
        "gene",
        "uk",
        "chemotherapy",
        "icr",
        "testing",
        "finding",
        "angelina",
        "mastectomy",
        "followup",
        "dr",
        "director",
        "support",
        "influencing",
        "prevent",
        "recurrence",
        "breakthrough",
        "work",
        "worldclass",
        "discovery",
        "pill",
        "use",
        "nhs",
        "astrazeneca",
        "msd",
        "access",
        "scheme",
        "doctor",
        "approval",
        "process",
        "trial",
        "brca1",
        "brca2",
        "surgery",
        "world",
        "day",
        "placebo",
        "year",
        "institute",
        "chairman",
        "committee",
        "study",
        "laboratory",
        "biology",
        "prostate",
        "prof",
        "tutt",
        "news",
        "olympia",
        "weakness",
        "survival",
        "approach",
        "option",
        "disease",
        "professor",
        "helin",
        "executive",
        "step",
        "group",
        "cancerfree",
        "europe",
        "delay"
    ],
    "category": [
        "wires",
        "pa"
    ]
}